Clinical Study
Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia
Table 1
Positivity of immunohistochemical targets within the epithelium.
| | NED | REC | | | | <5% | >5% | <5% | >5% | Fisher exact | Phi |
| CD4+ | 6 (27.3%) | 16 (72.7%) | 12 (100%) | 0 (0%) | <0.0001 | −0.70 | CD8+ | 19 (86.4%) | 3 (13.6%) | 10 (83.3%) | 2 (16.7%) | n.s. | 0.04 | T-bet+ | 4 (18.2%) | 18 (81.8%) | 12 (100%) | 0 (0%) | <0.0001 | −0.78 | GATA3+ | 22 (100%) | 0 (0%) | 10 (83.3%) | 2 (16.7%) | n.s. | 0.34 | CD11c+ | 11 (50%) | 11 (50%) | 10 (83.3%) | 2 (16.7%) | n.s. | 0.22 |
|
|
NED: not evidence of disease; REC: recurrence of disease.
|